Clinical Trial Update: Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fulvestrant plus anastrozole versus anastrozole alone in luminal A-like postmenopausal advanced breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Fudan University | Conditions: Carcinoma Breast Stage IV | Phase 2 | Status: WITHDRAWN